Buying Signals

Eli Lilly remains a 'strong buy' as I see robust revenue growth across obesity, diabetes, immunology, and oncology franchises. LLY's MOUNJARO and ZEPBOUND delivered Q1 2026 revenues of $8.66B [+125%] and $4.16B [+80%] respectively, driving a 56% YoY total revenue increase. Pipeline momentum is strong: FOUNDAYO launched, Retatrutide and Eloralintide advanced, and EBGLYSS/JAYPIRCA show double-digit

Colgate-Palmolive delivered 8% sales growth in Q1 2026, but EPS declined 6%, warranting a conservative hold rating. I see organic growth of just 2.9%, with North America sales falling due to increased toothpaste competition and margin compression. FX tailwinds drove significant growth in Latin America, EMEA, and APAC, raising concerns about sustainability if currency trends reverse.

Becton, Dickinson and Company NYSE: BDX reported fiscal second-quarter revenue and adjusted earnings ahead of its internal expectations, while management raised its full-year adjusted earnings outlook and said growth was broad-based across most of the portfolio.

MNST tops Q1 2026 estimates as global energy drink demand, innovation and international growth fueled a 26.9% sales jump.

Monster Beverage NASDAQ: MNST reported what CEO Hilton Schlosberg called “another quarter of strong financial results and cash generation,” highlighted by fiscal first-quarter net sales topping $2 billion for the first time in company history. Net sales rose 26.9% year over year to $2.35 billion, with double-digit growth across all geographic regions and share gains in a number of markets, accordi

POST's Q2 profit beats estimates as Foodservice EBITDA jumps 47.9% and gross margin expands to 30.2%.

ABT's Medical Devices segment posts 8.5% Q1 growth as Electrophysiology, Rhythm Management and Heart Failure deliver strong gains.

Post Holdings (POST) came out with quarterly earnings of $1.94 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $1.41 per share a year ago.

While the top- and bottom-line numbers for Post Holdings (POST) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Monster Beverage (MNST) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.47 per share a year ago.

The energy-drink maker said international sales were up almost 45% for the quarter at over $1 billion, and now make up about 45% of its total revenue.

Monster Beverage beat Wall Street expectations for first-quarter revenue and profit on ​Thursday, as demand for energy drinks ‌remained strong despite broader economic uncertainty.

ST. LOUIS, May 7, 2026 /PRNewswire/ -- Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today reported results for the second fiscal quarter ended March 31, 2026. Highlights: Second quarter net sales of $2.0 billion Operating profit of $211.9 million; net earnings of $81.9 million and Adjusted EBITDA (non-GAAP)* of $395.0 million Affirmed fiscal year 2026 Adjusted EBITDA

2026 First Quarter Highlights  Net Sales rise 26.9 percent to $2.35 billion Operating Income increases 28.1 percent to $730.0 million (24.1 percent to $733.5 million on a non-GAAP adjusted basis) 1 Net Income increases 28.6 percent to $569.5 million (24.6 percent to $572.4 million on a non-GAAP adjusted basis) Net Income Per Diluted Share increases 27.6 percent to $0.58 per share (23.7 percent to

Mounjaro generated $8.66 billion in sales in the first quarter.

BDX beats second-quarter fiscal 2026 earnings and revenue estimates, driven by broad segment strength and improved profitability.

While the top- and bottom-line numbers for Becton Dickinson (BDX) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Kenvue (KVUE) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.24 per share a year ago.

Becton Dickinson (BDX) came out with quarterly earnings of $2.9 per share, beating the Zacks Consensus Estimate of $2.77 per share. This compares to earnings of $3.35 per share a year ago.

Becton Dickinson raised its annual profit forecast on Thursday, riding strong demand for its drug-delivery devices and surgical equipment, and appointed Vitor ​Roque as its chief financial officer.

Revenue of $4.7 billion increased 5.2% as reported, 2.6% FXN GAAP and adjusted diluted EPS from continuing operations of $(0.13) and $2.90, respectively Executed a $2.0 billion accelerated share repurchase (ASR) program and retired $2.1 billion of debt in the quarter Company reaffirms revenue growth guidance, raises full-year adjusted diluted EPS guidance1 FRANKLIN LAKES, N.J., May 7, 2026 /PRNews

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced financial results for the fiscal first quarter ended March 29, 2026. “Our year is off to an encouraging start, as our continued efforts to strengthen the business and sharpen execution resulted in delivering net and organic sales growth for the second consecutive quarter, along with meaningful year-over-year improvement in gro

ATLANTA--(BUSINESS WIRE)--Newell Brands Inc. (NASDAQ: NWL) announced today the declaration of a quarterly cash dividend of $0.07 per share. The dividend is payable June 15, 2026 to common stockholders of record at the close of trading on May 29, 2026. About Newell Brands Newell Brands (NASDAQ: NWL) is a leading global consumer goods company with a strong portfolio of well-known brands, including R

Eli Lilly And Co (NYSE:LLY) has capitalized on last week's impressive first-quarter earnings report.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 1.5% on Wednesday.

Post Holdings' Q2 performance is likely to benefit from Foodservice strength and Pet recovery gains, while softer cereal and dog food demand may have tempered growth.

Lilly surges after a Q1 beat and higher guidance, as Mounjaro and Zepbound fueled 56% revenue growth.

KHC beats first-quarter estimates on revenues and EPS, but organic sales slip as volume declines and cost pressures weigh on operating income.

Kraft Heinz Co (NASDAQ:KHC, XETRA:KHNZ) reported first quarter results that surpassed analyst expectations for both earnings and revenue, even as underlying sales trends remained slightly weaker. The packaged food company posted adjusted earnings per share of $0.58, ahead of the $0.50 consensus estimate, while revenue came in at $6.05 billion versus expectations of about $5.88 billion.

Amcor is reaffirmed as a Strong Buy, supported by robust fundamentals, an attractive ~6.9% dividend yield, and an undervalued share price despite a recent jump. Q3 FY26 results exceeded expectations, with 6% Adj. EPS growth and a solid 15.1% Adj. EBITDA margin, while portfolio optimization and divestitures show $2.5 billion in potential proceeds. Revised guidance anticipates $1.5–$1.6 billion FCF

Amcor's Q3 sales surge 77% y/y on the Berry deal, beating estimates as margins improve, but softer demand and lower FY26 outlook temper the momentum.

While the top- and bottom-line numbers for Amcor (AMCR) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Kraft Heinz (KHC) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.62 per share a year ago.

Utz Brands (UTZ) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.16 per share a year ago.

THOMASVILLE, Ga., May 6, 2026 /PRNewswire/ -- Flowers Foods, Inc. (NYSE: FLO) will report its first quarter 2026 financial results on Thursday, May 21, 2026, after the market close.

Tyson Foods delivered a double-beat quarter, driven by strong Prepared Foods and Chicken segments, despite persistent headwinds in Beef. TSN raised operating income and free cash flow guidance, reflecting operational momentum, but growth appears priced in at a forward P/E near its 5-year average. The balance sheet continues to strengthen with $1 billion in debt reduction over the past year and rob

Amcor (AMCR) came out with quarterly earnings of $0.96 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.9 per share a year ago.

Kraft Heinz reported slightly higher first-quarter sales as it implements a strategy to turn around its business and return to growth before resuming a potential split into two separate companies.

PITTSBURGH & CHICAGO--(BUSINESS WIRE)--The Kraft Heinz Company (Nasdaq: KHC) announced today that the Company's Board of Directors declared a regular quarterly dividend of $0.40 per share of common stock payable on June 26, 2026, to stockholders of record as of June 5, 2026. ABOUT THE KRAFT HEINZ COMPANY Kraft Heinz (Nasdaq: KHC) is one of the world's largest food and beverage companies, with appr

PITTSBURGH & CHICAGO--(BUSINESS WIRE)--The Kraft Heinz Company (Nasdaq: KHC) (“Kraft Heinz” or the “Company”) today reported financial results for the first quarter of 2026. “Our first quarter results demonstrate steady progress, and I am encouraged by the early signs of momentum we're building,” said Steve Cahillane, CEO of Kraft Heinz. “The investments we made in 2025 are now driving early tract

HANOVER, Pa.--(BUSINESS WIRE)--Utz Brands, Inc. (NYSE: UTZ) (“Utz” or the “Company”), a leading U.S. manufacturer of branded Salty Snacks and a small-cap growth and value Staples equity, today reported financial results for the Company's first fiscal quarter ended March 29, 2026. 1Q'26 Summary(1) Net Sales increased 2.6% to $361.3 million Total Organic Net Sales increased 2.6%; Branded Salty Snack

Novo Nordisk stock rose as it raised its guidance on the back of the strong performance of its weight-loss pill.

ZURICH, May 6, 2026 /PRNewswire/ -- Highlights - Three Months Ended March 31, 2026 Net sales $5,914 million, up 77% driven by the Berry acquisition GAAP Net income $278 million including acquisition related costs and GAAP diluted EPS of $0.60 Acquisition synergies of $77 million, at upper end of expectations Adjusted EBITDA $892 million, up 87% and adjusted EBIT $687 million, up 79% Adjusted EBITD

Investors were cheered by management's rationalization measures.

BALL tops Q1 estimates with strong revenue and earnings growth, but rising costs squeeze margins despite higher volumes and favorable pricing across regions.

Pfizer beats Q1 estimates as new launches and acquired drugs lift sales, offsetting COVID declines, while the drugmaker reaffirms its 2026 outlook.

Pfizer (PFE) delivered a stronger-than-expected first quarter as demand for several older blockbusters helped cushion the continued drop in Covid-related revenu

Pfizer Inc (NYSE:PFE, XETRA:PFE) reported first-quarter 2026 revenue and adjusted profit above Wall Street expectations on Tuesday, driven by strong growth in its launched and acquired products, as the drugmaker reaffirmed its full-year financial outlook. The pharmaceutical giant posted revenue of $14.5 billion for the quarter ended March 31, up 5% from a year earlier and ahead of analyst estimate

PepsiCo (NASDAQ: PEP | PEP Price Prediction) and Coca-Cola (NYSE: KO) just delivered first quarter results that expose a widening gap between the two beverage giants.

KHC heads into first-quarter earnings with sales and profit seen falling as weak demand, inflation and higher marketing spend weigh on near-term performance.

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Tuesday.

Tyson Foods is quietly outperforming, with shares up about 20% and at new 52-week highs. The meatpacking king also gained about 8% following the release of its Q2, which topped expectations. The company has benefitted from ongoing strength in its Chicken business, which continues to see soaring demand.

Pfizer reported Q1 revenues of $14.5bn, with adjusted EPS down 18% and a 6.54% dividend yield. PFE faces major patent expirations on key drugs like Eliquis and Vyndaqel, pressuring future revenues despite recent M&A and pipeline efforts. Recent acquisitions, including Seagen, have yet to deliver material commercial upside, while high debt limits further M&A flexibility, although the Metsera deal i

Pfizer Inc  (NYSE:PFE) stock is down 1.1% to trade at $26.03 at last check.

Although the revenue and EPS for Pfizer (PFE) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Although the revenue and EPS for Ball (BALL) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Beyond analysts' top-and-bottom-line estimates for Kraft Heinz (KHC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2026.

Beyond analysts' top-and-bottom-line estimates for Becton Dickinson (BDX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2026.

Pfizer (PFE) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.92 per share a year ago.

Graphic Packaging (GPK) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.51 per share a year ago.

Higher sales of cancer treatments helped fuel better-than-expected first-quarter sales and profit for the drugmaker.

Ball (BALL) came out with quarterly earnings of $0.94 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.76 per share a year ago.

The Kraft Heinz Company (NASDAQ:KHC) will release earnings for its first quarter before the opening bell on Wednesday, May 6.

Pfizer posted higher first-quarter revenue but lower profit that was weighed down partially by higher research and development spending.

The drugmaker has been leaning on recently acquired products to offset a looming patent cliff.

Increased Net Sales by 2% with volumes up 1% year-over-year Reduced inventory by $48 million during the quarter Completed 90-day comprehensive business review; advancing near-term strategic priorities Executed cost reduction and operational efficiency initiatives Reaffirming guidance for full year 2026, including delivering Adjusted Cash Flow in the range of $700 million to $800 million ATLANTA, M

Highlights First quarter U.S. GAAP total diluted earnings per share of 77 cents vs. 63 cents in 2025 First quarter comparable diluted earnings per share of 94 cents vs.

AUSTIN, Minn., May 4, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE: HRL), a Fortune 500 global branded food company, invites interested parties to participate in a webcast and conference call with Jeff Ettinger, interim chief executive officer; John Ghingo, president; and Paul Kuehneman, interim chief financial officer and controller, to discuss the Company's second quarter financial result

Tyson Foods (TSN) saw its stock rise modestly following the release of its Q2 results for March. The protein supplier exceeded earnings per share (EPS) expectat

AbbVie ABBV stock has risen around 5% since it announced robust first-quarter 2026 results on April 29. It beat estimates for both earnings and sales and the guidance for 2026 revenues and earnings was also raised.

BD rides on Medical and Interventional product momentum, but China dynamics and research funding could weigh on second-quarter fiscal 2026 results.

AMCR heads into Q3 earnings release with strong y/y revenue growth forecasts, but weak demand, cost pressures and a negative ESP cloud the outlook.

TSN reports fiscal second-quarter results with EPS beating estimates and sales rising 4.4%, driven by pricing gains despite volume declines.

Church & Dwight Co., Inc. (NYSE:CHD) reported upbeat first-quarter 2026 results on Friday.

Interparfums heads into its May 5 Q1 earnings report with EPS seen down 13.6%, as tariffs, FX costs and promo spending squeeze margins.

Tyson Foods Inc (NYSE:TSN) reported fiscal second quarter results that exceeded Wall Street expectations, as stronger demand in its chicken business helped offset mixed performance across other segments. For the quarter ended March 28, 2026, the US meat processor posted adjusted earnings per share of $0.87, ahead of analyst estimates of $0.78.

While the top- and bottom-line numbers for Tyson (TSN) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Tyson Foods (TSN) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.92 per share a year ago.

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 150 points on Monday.

I keep buying Eli Lilly (NYSE:LLY | LLY Price Prediction), and the latest quarter just made it harder to stop.

Mounjaro and Zepbound are driving Eli Lilly's earnings sharply higher. Foundayo looks like another top-seller.

Colgate-Palmolive remains a Buy, supported by resilient fundamentals, an attractive and still sustainable dividend yield while they hold the Dividend King status, and prudent valuation amid macro and geopolitical headwinds. CL posted solid Q1 results, with 8.4% net sales growth, robust free cash flow, and reaffirmed 2026 sales and EPS growth guidance despite Iran-driven margin pressures. Rising in

Net Sales: Increased by 0.2%, exceeding expectations for a decline.Organic Sales Growth: 5%, surpassing the 3% outlook.Adjusted Gross Margin: Expanded by 130 b

Organic Sales Growth: Accelerated from the fourth quarter, driven by improved volume performance, particularly in Asia Pacific.Volume and Pricing Growth: Achie

Although it posted a loss for the period, Newell edged past analyst estimates on both the top and bottom lines. It also raised certain full-year guidance items.

Clorox Corporation (NYSE:CLX) posted upbeat third-quarter results and updated full-year guidance on Thursday.

CL beats Q1 earnings estimates as pricing and volume lift sales 8.4%; costs and SGPP charges weigh on margins, but outlook stays intact.

NWL narrows Q1 loss, beats sales estimates, and lifts 2026 outlook as pricing, demand and margin gains signal improving momentum despite softer volumes.

Release Date: April 30, 2026For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points The Hershey Co

Clorox tops Q3 EPS estimates on cost cuts despite flat sales. It trims the FY26 outlook after GOJO close and bigger margin pressure.

Conagra Brands (CAG) reported earnings 30 days ago. What's next for the stock?

Q1 net sales rose 0.2% to $1.469B; organic sales up 5.0% driven by 5.3% volumeGAAP EPS $0.91; Adjusted EPS $0.95, both below the $0.99 consensusAdjusted gross

On May 1, 2026, Colgate-Palmolive Co (CL) released its 8-K filing reporting first-quarter 2026 results. Net sales rose 8.4% year over year to $5,324 million, wh

While the top- and bottom-line numbers for Colgate-Palmolive (CL) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

While the top- and bottom-line numbers for Church & Dwight (CHD) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

While the top- and bottom-line numbers for Newell Brands (NWL) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

CHD beats Q1 estimates as organic sales jump 5% and gross margin widens, even with inflation and tariffs weighing on costs.

BALL heads into Q1 earnings with sales and profit growth expected, but the model signals no clear beat as tariff costs and mixed segment outlook weigh.

Church & Dwight (CHD) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.91 per share a year ago.

Colgate-Palmolive (CL) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.91 per share a year ago.

Newell Brands (NWL) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.01 per share a year ago.

Colgate-Palmolive beat expectations for first-quarter sales and profit on Friday, helped by strong international demand for household staples such as oral ​and personal care products.

Church & Dwight's profit slipped on higher costs in the first quarter, offsetting strong performance across its main segments, which lifted revenue above company guidance.

The maker of consumer products, including toothpaste, deodorant and soap, posted net income of $646 million, or 80 cents a share, down from $690 million, or 85 cents a share, the year prior.

Newell Brands reported lower first-quarter sales but raised its full-year sales outlook on expectations that its turnaround strategy will soon drive a return to topline growth.

EWING, N.J.--(BUSINESS WIRE)--Church & Dwight Co., Inc. (NYSE: CHD) today announced that the Company exceeded its first quarter outlook with stronger than expected sales, gross margin expansion, earnings growth and continued market share gains across its global portfolio. Reflecting our 2025 strategic portfolio actions, first quarter 2026 net sales increased 0.2% to $1,469.3 million, exceeding the

ATLANTA--(BUSINESS WIRE)--Newell Brands (NASDAQ: NWL) today announced its first quarter 2026 financial results. Chris Peterson, Newell Brands President and Chief Executive Officer, said, "First quarter results came in ahead of plan across all key metrics with all three segments delivering core sales above our expectations. Higher than expected consumer demand for our products, as evidenced by impr

Gross Margin: Below expectations due to higher-than-expected supply chain costs and delayed cost savings.Release Date: April 30, 2026For the complete transcrip

The headline numbers for Clorox (CLX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Clorox (CLX) came out with quarterly earnings of $1.64 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.45 per share a year ago.

Cardinal Health beats Q3 EPS estimates and raises 2026 outlook, fueled by pharma and specialty growth despite a revenue miss.

PPC misses earnings estimates as margins weaken, but Prepared Foods growth and Just Bare's momentum support sales and long-term expansion efforts.

At 32x earnings, some investors would push back on the idea that MDLZ is a value stock. But forward earnings of about 20x hints that it could be a value play.

Baxter beats Q1 earnings and revenue estimates, sending shares higher despite declining profits and margin contraction.

The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Post Holdings (POST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

US Foods (USFD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CORONA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) announced today that results for its first quarter ended March 31, 2026, will be reported on Thursday, May 7, 2026, after the close of the market.

While the top- and bottom-line numbers for Cardinal (CAH) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Baxter International (BAX) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.55 per share a year ago.

Cardinal Health (CAH) came out with quarterly earnings of $3.17 per share, beating the Zacks Consensus Estimate of $2.8 per share. This compares to earnings of $2.35 per share a year ago.

Baxter on Thursday beat Wall Street estimates for first-quarter profit and revenue, helped by robust sales ​in its medical products and therapies unit.

Sonoco Products is rated a Buy, offering a 4.3% yield and trading at a 20% discount to fair value. SON's 43-year dividend growth streak and strong customer retention underpin reliable, inflation-beating income. Despite near-term margin pressure and cautious guidance, I expect 7% EPS growth and 4.5% dividend CAGR over five years.

Cardinal Health raises its fiscal-year adjusted earnings guidance for the second time this year, helping investors look past mixed quarterly performance.

Cardinal Health once again raised its full-year outlook after logging higher-than-expected adjusted earnings in the third quarter.

On April 30, 2026, Baxter International Inc (BAX) released its 8-K filing detailing first-quarter 2026 results. Sales from continuing operations were $2.7 billi

Drug distributor Cardinal Health on Thursday raised its 2026 profit forecast range, betting on ​strong demand for costly specialty medicines and branded ‌drugs at its pharmaceuticals unit.

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global medtech leader, today reported results for the first quarter of 2026. “Financial results for the quarter overall were in line with our expectations, and we are making progress to stabilize the business, embed a culture of continuous improvement, and strengthen execution,” said Andrew Hider, president and CEO. “Althou

Unilever PLC (LSE:ULVR) said it is launching a €1.5 billion share buyback today as it posted better-than-expected growth for the first quarter of the year, with volume growth driving a rise in underlying sales. The owner of consumer brands ranging from Cif and Colgate to Hellman's and Marmite reported 3.8% underlying sales growth in the first three months of 2026, with volumes up 2.9% and pricing

Underlying sales rose 3.8%, as the consumer-goods company carries out its largest portfolio shuffle yet.

Unilever's first-quarter underlying sales growth beat expectations on Thursday, driven by a ‌return to volume-led growth in emerging markets and strong demand for its "power brands" including Dove and Vaseline as it wins back customers.

Pilgrim's Pride (PPC) came out with quarterly earnings of $0.51 per share, missing the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $1.31 per share a year ago.

WESTMINSTER, Colo., April 29, 2026 /PRNewswire/ -- Ball Corporation 's (NYSE: BALL) board of directors (the "Board") today declared a cash dividend of 20 cents per share, payable June 15, 2026, to shareholders of record as of June 1, 2026.

The chicken and pork manufacturer reported a lower profit but higher revenue in the first quarter, citing resilient chicken demand.

GREELEY, Colo., April 29, 2026 (GLOBE NEWSWIRE) -- Pilgrim's Pride Corporation (NASDAQ: PPC), one of the world's leading food companies, reports its first quarter 2026 financial results.

MDLZ posts first-quarter earnings and sales beat, as revenue growth is offset by profit decline amid higher costs and weaker margins.

Edgewell Personal (EPC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kraft Heinz (KHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Amcor (AMCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Although the revenue and EPS for Silgan (SLGN) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Silgan Holdings (SLGN) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.82 per share a year ago.

NORWALK, Conn.--(BUSINESS WIRE)--SILGAN ANNOUNCES FIRST QUARTER 2026 RESULTS.

Release Date: April 28, 2026For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Mondelez Intern

The headline numbers for Mondelez (MDLZ) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Mondelez (MDLZ) came out with quarterly earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $0.74 per share a year ago.

The food company, whose brands include Oreo and Cadbury, logged a profit of $560 million boosted by double-digit growth in Latin America and the Asia, Middle East, and Africa region.

PARSIPPANY, N.J.--(BUSINESS WIRE)--B&G Foods, Inc. (NYSE: BGS) announced today that it intends to issue a press release with first quarter 2026 financial results after the market close on Tuesday, May 12, 2026. B&G Foods has scheduled a conference call at 4:30 p.m. ET that same day to discuss the results. Hosting the call will be Casey Keller, President and Chief Executive Officer and Bruce Wacha,

AVY beats Q1 earnings estimates on strong volumes and cost control, with profits rising and cash flow swinging to positive despite mixed segment performance.

KMB posts first-quarter earnings and sales beat, driven by organic growth and productivity gains, while margins slip and outlook signals steady 2026 growth.

EL's fiscal third-quarter results are likely to show sales and earnings growth, though margins may face pressure from tariffs and consumer-facing investments.

SYY's Q3 FY26 EPS and sales miss estimates as incentive comp surges, even with accelerating volumes and gross margin expansion.

Ball (BALL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

QuidelOrtho (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Energizer (ENR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Graphic Packaging (GPK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Smithfield Foods, Inc. (SFD) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.58 per share a year ago.

Crown Holdings (CCK) came out with quarterly earnings of $1.86 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.67 per share a year ago.

TAMPA, Fla., April 27, 2026 /PRNewswire/ -- Crown Holdings, Inc. (NYSE: CCK) today announced its financial results for the first quarter ended March 31, 2026.

PPC's prepared foods surge and Big Bird conversion highlight a shift toward higher-value products, supporting growth despite commodity headwinds.

BAX heads into Q1 earnings with revenues and profit set to fall sharply as operational pressures, weak demand and product disruptions weigh on results.

NWL's Q1 results are likely to show falling sales and profits as tariffs, shipment timing issues and cautious retailer orders pressure margins.

MO's first-quarter results are likely to show modest growth, as pricing strength and cost control offset volume declines in smokeable products.

Crown Castle is reaffirmed as a Buy, with risks looking priced in and a strong, improving business returning to its core US cell tower operations. Q1 2026 saw solid AFFO and revenue beats, with a $1 billion buyback program and $7 billion in debt repayments expected from the fiber sale and a ~4.86% dividend yield. Guidance anticipates a 5% decline in site rental revenue but 1% AFFO growth (+2% per

Ball Corporation remains a Hold, as shares are fairly valued relative to peers despite recent outperformance. 2025 saw revenue rise to $13.16B and net income more than double to $912M, driven by higher aluminum prices and volumes. Management projects 10%+ EPS growth for 2026, aided by recent acquisitions and ongoing portfolio optimization.